BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34313632)

  • 1. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
    Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
    J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
    Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
    J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
    Harashima S; Yamazaki Y; Motomura N; Ono Y; Omata K; Tezuka Y; Morimoto R; Nakamura Y; Satoh F; Suzuki H; Kwon GE; Choi MH; Sasano H
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106116. PubMed ID: 35533918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and metabolic characters of
    Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
    Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
    Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
    Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
    Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
    De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
    Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
    Lenzini L; Rossitto G; Maiolino G; Letizia C; Funder JW; Rossi GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1089-95. PubMed ID: 26066531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
    Lee BC; Kang VJ; Pan CT; Huang JZ; Lin YL; Chang YY; Tsai CH; Chou CH; Chen ZW; Liao CW; Chiu YW; Wu VC; Hung CS; Chang CC; Lin YH
    Front Endocrinol (Lausanne); 2022; 13():830130. PubMed ID: 35311227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
    Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
    Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
    Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
    Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
    Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.